OncoMatch/Clinical Trials/NCT07652489

Surgery Plus Postoperative Radiotherapy for T4 Sinonasal Adenoid Cystic Carcinoma: A Prospective Observational Study

Is NCT07652489 recruiting? Yes, currently enrolling (Sep 2026).

RecruitingEye & ENT Hospital of Fudan UniversityNCT07652489Data as of Sep 2026Location: China

Extracted eligibility criteria

Cancer type

Head and Neck Squamous Cell Carcinoma

Performance status

ECOG 0–2(Ambulatory, capable of self-care)

Demographics

Ages ≤ 80

Prior therapy

No prior treatment (treatment-naive required)

Max 0 prior lines

Cannot have received: radiotherapy

Previously untreated (no radiotherapy...)

Cannot have received: chemotherapy

Previously untreated (no...chemotherapy...)

Cannot have received: targeted therapy

Previously untreated (no...targeted therapy...)

Cannot have received: immunotherapy

Previously untreated (no...immunotherapy...)

Cannot have received: tumor resection

Previously untreated (no...tumor resection)

Lab requirements

Blood counts

anc ≥1.5×10⁹/l, platelets ≥100×10⁹/l, hb ≥90 g/l

Kidney function

cr ≤1.5×uln or crcl ≥50 ml/min

Liver function

alt/ast ≤2.5×uln, tbil ≤1.5×uln

Cardiac function

lvef ≥50%, no uncontrolled arrhythmia

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Is NCT07652489 currently recruiting?

Yes, this trial is currently recruiting patients.

Can patients have received prior systemic therapy?

No. This trial requires treatment-naive patients — prior systemic therapy is an exclusion criterion.

Is there an age limit?

Yes. Patients must be 80 years or younger.

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.